Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Type 1 Diabetes Mellitus Therapeutics Industry 2016 Global Market Growth, Trends, Demand, Share, Analysis to 2020

Thursday, October 13, 2016 1:10
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Type 1 Diabetes Mellitus (T1DM) is a chronic, progressive and serious disease characterized by a destruction or failure of insulin-secreting pancreatic beta cells, usually as a result of an autoimmune response. The resulting insulin deficiency prevents insulin-sensitive cells from carrying out essential glucose metabolism and leads to hyperglycemia (high blood glucose levels).

Browse more detail information about Type 1 Diabetes Mellitus Therapeutics Markets:

http://www.absolutereports.com/type-1-diabetes-mellitus-therapeutics-in-major-developed-markets-to-2021-innovative-and-diversified-pipeline-to-drive-market-growth-despite-patent-expirations-10070573

As a result, immediate and lifelong treatment with exogenous insulin therapy is initiated upon diagnosis of T1DM. Exogenous insulin has remained the mainstay of T1DM therapy since it was used to treat the first human patient in 1922.

Get a PDF Sample of Type 1 Diabetes Mellitus Therapeutics Markets:

http://www.absolutereports.com/enquiry/request-sample/10070573

 

Scope of Type 1 Diabetes Mellitus Therapeutics Markets:

The report assesses the current T1DM market and forecasts market trends to 2021. Areas covered include -

- An introduction to T1DM, which includes classification, symptoms, etiology, pathophysiology, co-morbidities and complications, diagnosis and treatment

- An analysis of the leading insulin therapies in the current T1DM marketed products landscape.

- An analysis of the pipeline for T1DM. This includes a breakdown of pipeline molecules by stage of development, molecule type, route of administration, molecular target and novelty. Trends in T1DM clinical trial size, duration and failure rates, by molecule type and molecular target are discussed. A comparative analysis of the most promising pipeline molecules is also provided.

- Forecast projections for the T1DM market to 2021. An analysis is provided for the global market and each of the eight major markets. The forecast incorporates projected, low and high variance scenarios based on treatment usage patterns and annual therapy costs in each of the major markets.

- An analysis of strategic consolidations, including co-development and licensing deals, within the T1DM indication.

 

Reasons to buy Type 1 Diabetes Mellitus Therapeutics Markets:

The report will provide clients with a strong understanding of the T1DM indication and an appreciation of the evolving landscape of the T1DM therapeutics market. The report will enable clients to -

- Appreciate the current T1DM marketed products landscape, including the dominant therapeutic strategies, products, and companies, and recognize gaps within the market and areas of unmet need

- Identify trends and developments within the T1DM pipeline and consider how the future competitive environment will be impacted.

- Consider market opportunities and potential risks by examining trends in T1DM clinical trial duration and size, as well as clinical trial failure rates, amongst clinical phases and molecule types

- Assess the potential clinical and commercial impact of current late-stage pipeline molecules on the T1DM therapeutics market

- Understand how strategic consolidations have shaped the current T1DM pipeline and marketed products landscapes

 

Have any query? ask our expert @ http://www.absolutereports.com/enquiry/pre-order-enquiry/10070573

 

List of Figures, Tables and Charts Available in Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 – Innovative and Diversified Pipeline to Drive Market Growth Despite Patent Expirations

1.1 List of Tables

Table 1: T1DM Therapeutics Market, Common Endpoints in T1DM Trials 25

Table 2: T1DM Therapeutics Market, Global, Breakdown of Multiple Molecular Targets, 2015 66

Table 3: T1DM Therapeutics Market, Global, Breakdown of ‘Other’ Molecular Targets, 2015 69

Table 4: T1DM Therapeutics Market, Global, All Pipeline Products, Discovery Phase, 2015 133

Table 5: T1DM Therapeutics Market, Global, All Pipeline Products, Preclinical Phase, 2015 134

Table 6: T1DM Therapeutics Market, Global, All Pipeline Products, IND/CTA-filed Phase, 2015 137

Table 7: T1DM Therapeutics Market, Global, All Pipeline Products, Phase I, 2015 138

Table 8: T1DM Therapeutics Market, Global, All Pipeline Products, Phase II, 2015 139

Table 9: T1DM Therapeutics Market, Global, All Pipeline Products, Phase III, 2015 140

Table 10: T1DM Therapeutics Market, Global, All Pipeline Products, Pre-registration Phase, 2015 140

Table 11: T1DM Therapeutics Market, Global, Market Forecast, 2014–2021 140

Table 12: T1DM Therapeutics Market, US, Market Forecast, 2014–2021 141

 

Get Discount on Type 1 Diabetes Mellitus Therapeutics Markets:

http://www.absolutereports.com/enquiry/request-discount/10070573

 

About Absolute Report:
Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market dedicated towards bringing you an ingenious concoction of data parameters.

Contact:
Mr. Ameya Pingaley

Absolute Reports
+1-408 520 9750
Email: sales@absolutereports.com
www.absolutereports.com  
Get more market research related news @
www.marketresearch.news        

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.